STEP – The lived experience of Parkinson’s disease
sponsored by UCB
Author: UCBPublished: 31 January 2018
Prep: Cook: Serves:
An innovative market research (“research”) programme, STEP™, aims to move beyond the focus on Parkinson’s symptoms to examine the real lived experience of Parkinson’s. We look at how the STEP™ programme sheds light on the impact of the condition on a person’s life, relationships and identity – and how it can help address the multiple dimensions of the condition
When people think of Parkinson’s, they are likely to think of the most widely recognised symptoms such as tremor and movement difficulties. But, as people living with the condition will emphasise, its impact goes much wider, affecting a person’s relationships and their sense of self.
A recent piece of research aimed to gain a fuller understanding of this impact. STEP™ was an innovative, ethnographic and context lab research programme undertaken in the UK, US and Canada. The programme included 63 people with Parkinson’s, between the ages of 40 and 76, who had lived with Parkinson’s for between six months and 21 years and had varied experiences of treatment. A total of 19 partners and those providing care, 18 healthcare professionals and other Parkinson’s experts also took part.
Researchers visited participants at home to glean first-hand experiences about living with the condition. People living with Parkinson’s and their loved ones were asked to speak freely about their experiences, and some also took part in group discussions where they shared the aspects that mattered most to them.
“People with Parkinson’s spoke freely about living with the condition”
The academics – who were anthropologists and strategists – also held in-depth one-to-one interviews with healthcare professionals and other experts who have frequent contact with people living with the condition, and visited the places where they interact.
The findings may not be that surprising to those familiar with Parkinson’s (see key insights from STEP™ research below), but researchers hope that this evidence-based research will help those who look after people with Parkinson’s to develop more appropriate and holistic approaches, with the confidence that they are addressing real needs. By giving a voice to people with Parkinson’s, STEP™ may well lead to solutions that improve how an individual views their experience of the condition.
Key insights from STEP™ research
In addition to key research insights, the findings suggest that people with Parkinson’s first experience the condition as a lifestyle disorder, then as intermittent periods of capability and loss, and finally as a loss of independence. Often forgotten in this are their loved ones who also experience a transition, with partners, friends and family members often becoming full-time caregivers as the condition progresses.
“By giving a voice to people with Parkinson’s, STEP™ may lead to better solutions”
Based on these insights, the following phases have been identified throughout the patient and loved-one or caregiver journey as Parkinson’s unfolds:
Pre-diagnosis – a person notices a ‘first sign’ such as a finger twitch. At first, these early symptoms are often rationalised as part of the natural ageing process.
Diagnosis – a moment of transition that alters a person’s understanding of their own physical health.
Lifestyle – a period of adjustment to a new way of life marked by mild to moderate limitations: Parkinson’s feels like a bother, not a disease.
Straddle – moving back and forth between pre-Parkinson’s life in “on” (medication is working and symptoms reduced) and glimpses of the disease in “off” moments (medication effect has worn off and symptoms become more severe).
Disease – after years of navigating “on” and “off” periods, the experience of Parkinson’s transforms into a ‘disease’ in the medical sense of the word. Unmanageable fluctuations, loss of independence, development of other conditions and medication side-effects begin to affect the patient’s entire personhood as they know it.
While every individual’s journey will be unique and complex, these common attributes allow those providing support to think about more than managing the physical symptoms. Incorporating the social, emotional and relationship aspects of living with Parkinson’s – and offering solutions as appropriate – can help both the person with Parkinson’s and their loved ones or caregivers to maximise positive outcomes along their journey. Ref: HQ/1217/NU/00088
UCB is a global biopharmaceutical company with a focus on neurology.
UCB is committed to identifying and addressing the unmet needs of people living with Parkinson’s disease to enable them to have a more engaged life every day.
This research was conducted by Idea Couture, now part of Cognizant Digital Works on behalf of UCB.
The authors thank the people living with Parkinson’s, and all other participants in addition to the researchers and their teams who contributed to this research.
STEP™ is a trademark of UCB Biopharma SPRL.
To access to the full report, please visit ucb.com.
This article is sponsored by UCB. The information in this article is given for information purposes only and does not represent an endorsement by Parkinson’s Europe of any particular treatments, products or companies. This article is not a substitute for advice from your doctor, pharmacist or other healthcare professional. Parkinson’s Life makes no representations or warranties of any kind, express or implied, about the completeness or accuracy of information provided.
“The lockdown has affected people with Parkinson’s in India immensely”
Dr Maria Barretto on how Covid-19 is impacting Parkinson’s community
2 weeks ago
Parkinson’s Europe co-founder Lizzie Graham wins World Parkinson Coalition award
Parkinson’s Europe co-founder Lizzie Graham has won a World Parkinson Coalition (WPC) award for her contribution to the Parkinson’s community. Lizzie is one of four people set to receive the Robin Elliott Award – which is given out every three years to individuals whose efforts best embody the goals and ethos of the WPC. She will be presented with the award in a ceremony at the World Parkinson’s Congress, which will be held in Barcelona later this year. Commenting on the news of Lizzie’s award, Parkinson’s Europe President, Veronica Clark, said: “Lizzie is Lizzie, and we love her for who she is and what she has done for us all – for people with Parkinson’s past and present and, I’m sure, future.” Lizzie co-founded the European Parkinson’s Disease Association (renamed Parkinson’s Europe last year) in 1992. She has since held several roles within the organisation – including secretary general and…
Study explores predictors of cognitive impairment in Parkinson’s disease
Cognitive impairment can affect some people with Parkinson’s – and may greatly impact their quality of life. Now, researchers in China have examined the possible risk factors for cognitive impairment in those with the condition. The study analysed data from 409 people with Parkinson’s within two years of their involvement in the Parkinson’s Progression Markers Initiative (PPMI) – an international study that follows people with and without the condition over time. The participants, who were newly diagnosed and experiencing normal cognitive function at the start of the research, were studied for at least five years. Published in ‘Frontiers in Aging Neuroscience’, the results indicate that older age at onset, high blood pressure and worse baseline motor symptoms may be among factors that could contribute to an increased risk of developing cognitive impairment. The researchers cautioned that “a larger sample and much more comprehensive assessment, and prolonged follow-up, will be required”.
Could frailty be a potential risk factor for Parkinson’s disease?
Frailty can refer to a reduction in physical function, and its attributes – including a slow walking speed and weak grip – are commonly experienced by people with Parkinson’s. Until now, there has been limited insight into the link between frailty and the risk of developing the condition over time. This is what led researchers at the Huazhong University of Science and Technology in China to analyse data from a large UK study, which was gathered over a 12-year period. Published in JAMA Neurology, the analysis found that frailty may be linked to an 87% higher risk of developing the condition. Commenting on the results, the researchers said: “These findings indicate that physical frailty is a potential risk factor for [Parkinson’s], and the assessment and management of frailty might have clinical significance in the at-risk population.”